Galectin Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	11.53	15.12	25.66	18.59	39.65	27.14
Cash & Short-Term Investments	11.53	15.12	25.66	18.59	39.65	27.14
Cash Growth	-57.41%	-41.08%	38.02%	-53.11%	46.08%	-42.84%
Prepaid Expenses	1.2	1.03	2.04	1.95	2.17	2.32
Other Current Assets	-	1.11	0.01	0.01	0.01	0.01
Total Current Assets	12.73	17.25	27.71	20.55	41.82	29.47
Property, Plant & Equipment	0.04	0.02	0.05	0.09	-	-
Other Long-Term Assets	0.1	0.23	0.44	0.65	0.01	0.14
Total Assets	12.87	17.5	28.2	21.29	41.83	29.6
Accounts Payable	5.39	5.66	6.43	3.89	1.81	1.29
Accrued Expenses	5	8.19	9.14	9.02	7.16	4
Current Portion of Long-Term Debt	126.02	21.12	-	-	-	-
Current Portion of Leases	0.04	0.02	0.05	0.04	0.01	0.04
Other Current Liabilities	-	0.43	0.06	0.06	0.07	0.07
Total Current Liabilities	136.45	35.41	15.68	13.01	9.03	5.4
Long-Term Debt	-	85.11	71.74	39.83	29.05	-
Long-Term Leases	-	-	0.02	0.07	-	0.01
Other Long-Term Liabilities	-	0.05	1	0.57	1.13	-
Total Liabilities	136.45	120.57	88.44	53.48	39.21	5.41
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	301.13	296.22	291.85	275.08	271	261.88
Retained Earnings	-426.98	-401.57	-354.37	-309.57	-270.69	-240
Total Common Equity	-125.79	-105.29	-62.46	-34.43	0.37	21.94
Shareholders' Equity	-123.58	-103.07	-60.24	-32.19	2.62	24.19
Total Liabilities & Equity	12.87	17.5	28.2	21.29	41.83	29.6
Total Debt	126.05	106.25	71.81	39.93	29.06	0.05
Net Cash (Debt)	-114.53	-91.13	-46.15	-21.34	10.59	27.09
Net Cash Growth	-	-	-	-	-60.90%	-42.90%
Net Cash Per Share	-1.81	-1.46	-0.77	-0.36	0.18	0.48
Filing Date Shares Outstanding	64.47	63.18	61.9	59.44	59.36	57.16
Total Common Shares Outstanding	64.47	63.16	61.85	59.43	59.34	57.08
Working Capital	-123.72	-18.16	12.03	7.54	32.79	24.07
Book Value Per Share	-1.95	-1.67	-1.01	-0.58	0.01	0.38
Tangible Book Value	-125.79	-105.29	-62.46	-34.43	0.37	21.94
Tangible Book Value Per Share	-1.95	-1.67	-1.01	-0.58	0.01	0.38
Machinery	-	0.07	0.07	0.07	0.07	0.07
Leasehold Improvements	-	0	0	0	0	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.